spacer
home > epc > autumn 2019 > unfamiliar grounds
PUBLICATIONS
European Pharmaceutical Contractor

Unfamiliar Grounds





Audit preparation can seem like a daunting task, especially when the subject area is complex or unfamiliar. It is often a balancing act between competing priorities and expectations, as well as being vigilant that the audit remains a quality assurance exercise (i.e., scratching the subject surface and verifying compliance through information sampling).

Know the Audit Scope

Very rarely are auditors in a position to attend an audit with little preparation. To do so would only set the audit up for disaster as essential audit objectives may not be met, with time spent on activities that were not a priority for the audit outcome.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


Iain Pulley is a GCP auditor with over 12 years of experience auditing both global pharmaceutical organisations and clinical trials. With a BSc (Hons) in Product Design, he is passionately process-orientated and places a strong emphasis on ensuring quality management systems add value to achieve right-first-time results. Iain has also successfully assisted and coached various organisations in preparation for receiving regulatory authority inspections.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Gerresheimer opens a new plant for the production of pharmaceutical primary plastic packaging in China

Düsseldorf/Changzhou, December 11, 2019 – A new plant for producing plastic pharmaceutical packaging has been set up in the Chinese city of Changzhou to help satisfy the high demand for Gerresheimer’s primary packaging in China in the future. Today the new facility will be officially opened.
More info >>

White Papers

eSource: Reducing Site Workload for Better, Faster, Safer Clinical Trials

Clinical Ink

Unlike traditional electronic data capture (EDC), SureSource, Clinical Ink’s eSource platform, was designed from the beginning to minimize clinical trial complexity for site users. A Site Impact Survey provides scientific evidence regarding the impact of SureSource from 517 site users. Results confirm it significantly reduces workload, lessens queries, and improves data quality compared to paper and EDC. In this white paper, we quantitatively evaluate survey outcomes, provide qualitative feedback from survey respondents, and highlight the observed benefits of SureSource for transforming clinical research.
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement